Patients with locally advanced esophageal carcinoma nonresponder to radiochemotherapy: Who will benefit from surgery?

Annals of Surgical Oncology

Volumn 14, Issue 7, 2007, Pages 2036-2044

  Piessen, Guillaume ^a   Briez, Nicolas ^a   Triboulet, Jean Pierre ^a,b   Mariette, Christophe ^a,b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b UNIV LILLE   (France)

Author keywords

Esophageal carcinoma; Radiochemotherapy; Salvage surgery; Treatment

Indexed keywords

BARIUM; CISPLATIN; FLUOROURACIL;

ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGUS CARCINOMA; ESOPHAGUS RESECTION; FEMALE; HEIGHT; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; MULTIVARIATE ANALYSIS; OVERALL SURVIVAL; PREDICTOR VARIABLE; PROSPECTIVE STUDY; RESPIRATORY TRACT DISEASE; SALVAGE THERAPY; SWALLOWING; UNIVARIATE ANALYSIS;

EID: 34250821688     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-007-9405-9     Document Type: Article

References (29)

1. Brenner B, Ilson DH, Minsky BD. Treatment of localized esophageal cancer. Semin Oncol 2004; 31:554-65
2. Mariette C, Triboulet JP. Is preoperative chemoradiation effective in treatment of oesophageal carcinoma? Lancet Oncol 2005; 6:635-7
3. Stahl M, Stuschke M, Lehmann N, Meyer HJ, Walz MK, Seeber S, et al. Chemoradiation with and without surgery in patients with locally advanced squamous cell carcinoma of the esophagus. J Clin Oncol 2005; 23:2310-7
4. Bedenne L, Michel P, Bouché O, Milan C, Mariette C, Conroy T, et al. Chemo-radiation followed by surgery compared to chemo-radiation alone in locally advanced operable oesophageal cancer: a randomised multicentric phase III trial (FFCD 9102). J Clin Oncol. 2007, in press
5. Jeremic B, Shibamoto Y, Acimovic L, Matovic Z, Milicic B, Milisavljevic S, et al. Accelerated hyperfractionated radiation therapy and concurrent 5-fluorouracil/cisplatin chemotherapy for locoregional squamous cell carcinoma of the thoracic esophagus: a phase II study. Int J Radiat Oncol Biol Phys 1998; 40:1061-6
6. Mariette C, Taillier G, Van Seuningen I, Triboulet JP. Factors affecting postoperative course and survival after en bloc resection for esophageal carcinoma. Ann Thorac Surg 2004; 78:1177-83
7. Di Fiore F, Lecleire S, Rigal O, Galais MP, Ben Soussan E, David I, et al. Predictive factors of survival in patients treated with definitive chemoradiotherapy for squamous cell esophageal carcinoma. World J Gastroenterol 2006; 12:4185-90
8. Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, et al. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone. Cancer 2001; 9:2165-74
9. Murakami M, Kuroda Y, Matsusue S, Okamoto Y, Nakajima T, Nishimura S, et al. Treatment results of esophageal carcinoma of clinical T3, T4M0: historical comparison between neoadjuvant chemoradiotherapy followed by surgery or definitive radiotherapy and conventional surgery. Oncol Rep 2000; 7:571-8
10. Mariette C, Finzi L, Fabre S, Balon JM, Van Seuningen I, Triboulet JP. Factors predictive of complete resection of operable esophageal cancer: a prospective study. Ann Thorac Surg 2003; 75:1720-6
11. Piessen G, Mariette C, Triboulet JP. Cervical and upper-third thoracic esophageal carcinoma: a single pathological entity? Ann Chir 2005; 130:86-91
12. Manshanden CG, Hulscher JB, Hovius M, Fockens P, van Lanschot JJ, Obertop H. Limited resection for carcinoma of the upper thoracic oesophagus is not a realistic option. Eur J Surg Oncol 2000; 26:561-6
13. Westerterp M, van Westreenen HL, Reitsma JB, Hoekstra OS, Stoker J, Fockens P, et al. Esophageal cancer: CT, endoscopic US, and FDG PET for assessment of response to neoadjuvant therapy-systematic review. Radiology 2005; 236:841-51
14. Mariette C, Balon JM, Maunoury V, Taillier G, Van Seuningen I, Triboulet JP. Value of endoscopic ultrasonography as a predictor of long-term survival in oesophageal carcinoma. Br J Surg 2003; 90:1367-72
15. Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al. (Eds). AJCC Cancer Staging Manual, 6th ed., New York: Springer Verlag, 2002
16. Mariette C, Piessen G, Lamblin A, Mirabel X, Adenis A, Triboulet JP. Impact of preoperative radiochemotherapy on postoperative course and survival in patients with locally advanced squamous cell oesophageal carcinoma. Br J Surg 2006; 93:1077-83
17. Bedenne L, Seitz JF, Milan C, Renard P, Fraisse J, Conroy T, et al. Cisplatin, 5-FU and preoperative radiotherapy in esophageal epidermoid cancer. Multicenter phase II FFCD 8804 study. Gastroenterol Clin Biol 1998; 22:273-81
18. Zuccaro G Jr, Rice TW, Goldblum J, Medendorp SV, Becker M, Pimentel R, et al. Endoscopic ultrasound cannot determine suitability for esophagectomy after aggressive chemoradiotherapy for esophageal cancer. Am J Gastroenterol 1999; 94:906-12
19. Beseth BD, Bedford R, Isacoff WH, Holmes EC, Cameron RB. Endoscopic ultrasound does not accurately assess pathologic stage of esophageal cancer after neoadjuvant chemoradiotherapy. Am Surg 2000; 66:827-31
20. Brucher BL, Weber W, Bauer M, Fink U, Avril N, Stein HJ, et al. Neoadjuvant therapy of esophageal squamous cell carcinoma: response evaluation by positron emission tomography. Ann Surg 2001; 233:300-9
21. Levine EA, Farmer MR, Clark P, Mishra G, Ho C, Geisinger KR, et al. Predictive value of 18-fluoro-deoxy-glucose-positron emission tomography (18F-FDG-PET) in the identification of responders to chemoradiation therapy for the treatment of locally advanced esophageal cancer. Ann Surg 2006; 243:472-8
22. Reed CE, Eloubeidi MA. New techniques for staging esophageal cancer. Surg Clin North Am. 2002; 82:697-710
23. Woronoff AS, Mercier M, Gignoux M, Triboulet JP, Chaillard G, Bosset JF. Prognostic factors in operable epidermoid esophageal cancers. Gastroenterol Clin Biol 1998; 22:168-74
24. Elias D, Lasser P, Hatchouel JM, Escudier B, Spielmann M, Girinsky T, et al. A multivariate prospective study of prognostic factors in 200 operated epidermoid cancers of the esophagus. Definition of patients for whom surgical resection was of benefit. Gastroenterol Clin Biol 1993; 17:17-25
25. Sugimachi K, Watanabe M, Sadanaga N, Ikebe M, Mori M, Kitamura K, et al. Pre-operative estimation of complete resection for patients with oesophageal carcinoma. Surg Oncol 1994; 3:327-34
26. Picus D, Balfe DM, Koehler RE, Roper CL, Owen JW. Computed tomography in the staging of esophageal carcinoma. Radiology 1983; 146:433-8
27. Downey RJ, Akhurst T, Ilson D, Ginsberg R, Bains MS, Gonen M, et al. Whole body 18FDG-PET and the response of esophageal cancer to induction therapy: results of a prospective trial. J Clin Oncol 2003; 21:428-32
28. Laterza E, de Manzoni G, Guglielmi A, Rodella L, Tedesco P, Cordiano C. Endoscopic ultrasonography in the staging of esophageal carcinoma after preoperative radiotherapy and chemotherapy. Ann Thorac Surg 1999; 67:1466-9
29. Swisher SG, Erasmus J, Maish M, Correa AM, Macapinlac H, Ajani JA, et al. 2-Fluoro-2-deoxy-D-glucose positron emission tomography imaging is predictive of pathologic response and survival after preoperative chemoradiation in patients with esophageal carcinoma. Cancer 2004; 101:1776-85